NC
DXCM icon

NewSquare Capital’s DexCom DXCM Stock Holding History

NewSquare Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-178
Closed -$15.5K – 469
2025
Q2 		$15.5K Buy
178
+82
+85% +$6.43K ﹤0.01% 535
2025
Q1 		$6.56K Buy
96
+64
+200% +$5.22K ﹤0.01% 630
2024
Q4 		$2.49K Buy
+32
New +$2.37K ﹤0.01% 494
2023
Q3 		– Sell
-34
Closed -$4.37K – 665
2023
Q2 		$4.37K Sell
34
-32
-48% -$3.87K ﹤0.01% 438
2023
Q1 		$7.67K Buy
66
+32
+94% +$3.58K ﹤0.01% 378
2022
Q4 		$3.85K Buy
+34
New +$3.73K ﹤0.01% 400

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NewSquare Capital's DXCM Position: Q3 2025 in Review

NewSquare Capital sold out of DexCom (DXCM) in Q3 2025, closing a stake of 178 shares — an estimated $15.5K sold.

NewSquare Capital first reported a position in DXCM in Q4 2022 and held it in 6 quarters. The position peaked at $15.5K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • NewSquare Capital reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 178 DexCom shares in Q3 2025, an estimated $15.5K.
  • NewSquare Capital first reported a position in DexCom in Q4 2022 and held it in 6 quarters.
  • NewSquare Capital's DexCom position peaked at $15.5K in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.